|
|
|
| SULPIRIDE | ||
|
PRODUCT IDENTIFICATION |
||
| CAS NO. | 15676-16-1 |
|
| EINECS NO. | 239-753-7 | |
| FORMULA | C15H23N3O4S | |
| MOL WT. | 341.42 | |
|
H.S. CODE |
||
|
TOXICITY |
||
| SYNONYMS | N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide; | |
| (±)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide; (±)-Sulpiride; Sulpirida; | ||
| SMILES |
|
|
|
CLASSIFICATION |
||
|
PHYSICAL AND CHEMICAL PROPERTIES |
||
| PHYSICAL STATE |
white to off-white crystalline powder |
|
| MELTING POINT | 180 - 185 C | |
| BOILING POINT | ||
| SPECIFIC GRAVITY | ||
| SOLUBILITY IN WATER | Insoluble | |
| pH | ||
| VAPOR DENSITY |
|
|
| AUTOIGNITION |
|
|
| NFPA RATINGS | ||
|
REFRACTIVE INDEX |
||
| FLASH POINT | ||
| STABILITY |
Stable under ordinary conditions. |
|
|
GENERAL DESCRIPTION & APPLICATIONS |
||
| Sulpiride is a D-2-dopamine receptor antagonist which affects the level of a chemical messenger (neurotransmitter) in the brain called dopamine. It is used as an antidepressant and antipsychotic in the treatment of schizophrenia, hypomania and other psychoses. It is a white crystalline powder; slightly soluble in water; soluble in ethanol and 0.1 N HCl; administered orally and intramuscularly. The chemcial designation is N-[(1-Ethyl-2-pyrrolidinyl)methyl]-2- methoxy-5-sulfamoylbenzamide. | ||
| SALES SPECIFICATION | ||
|
APPEARANCE |
white crystalline powder | |
|
IDENTIFICATION |
Complies Test A,B |
|
| PURITY |
98.5% min |
|
| MELTING POINT |
175 - 185 C |
|
|
HEAVY METALS |
10ppm max |
|
|
LOSS ON DRYING |
0.5% max |
|
|
RESIDUE ON IGNITION |
0.1% max | |
| TRANSPORTATION | ||
| PACKING |
|
|
| HAZARD CLASS | ||
| UN NO. | ||
| OTHER INFORMATION | ||
|
|
|
